|
Prospector Profile 07.1665
|
|
HealthSport, Inc. |
NAICS |
325412 |
7633 East 63rd Place, Suite 220
Tulsa, OK 74133 |
Description |
Pharmceuticals Mfg. |
(888) 570-4776 |
Employees |
4 |
http://www.healthsportinc.com/ |
Revenue |
(mil) |
0.0010 |
|
Income |
(mil) |
-1.4380 |
|
Assets |
(mil) |
4.6520 |
|
Liability |
(mil) |
0.0570 |
|
(for the year ended 2006-12-31) |
|
Category:
Loss/Deficit
|
|
Event:
Healthsport, Inc. reported a net loss of $3.0 million for the third quarter ended Sept. 30, 2007, compared with a net loss of $296,107 in the comparable period in 2006. Net loss was $6.9 million during the nine months ended Sept. 30, 2007, compared with a net loss of $1.1 million in the nine months ended Sept. 30, 2006. Total costs and expenses increased to $7.0 million from $392,982 in the nine months ended Sept. 30, 2006. At Sept. 30, 2007, the company's consolidated balance sheet showed $30.6 million in accumulated deficit and $32.6 million in total stockholders' equity.
|
|
Intellectual Property:
The Company seeks to obtain and maintain patents and other intellectual property rights to restrict the ability of others to market products that compete with its products. The Company currently has five patent applications pending in the U.S. of which three are currently undergoing active examination. Two of these applications have received substantive actions from the United States Patent and Trademark Office and appropriate responses have been or will be filed. [SEC Filing SB-2 06-01-07]
|
|
Description:
The Company engages in the development, manufacture, and marketing of edible film strip products containing nutritional supplements and over-the-counter drugs in the United States.
|
|
Officers:
Daniel J. Kelly (Pres. & CEO); Ross E. Silvey (Interim CFO & Dir.); Jason Freeman (Dir.); Hank Durschlag (Dir.)
|
|
Auditor:
Creason & Associates PLLC
|
|
Securities:
Common Stock-Symbol HSPO.OB; OTC BB;
41,766,897 common shares outstanding as of September 30, 2007.
|
|
|
|
return to main page |
|
|